| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Large B-Cell, Diffuse | 26 | 2024 | 1399 | 4.000 |
Why?
|
| Hodgkin Disease | 16 | 2023 | 1376 | 2.510 |
Why?
|
| Lymphoma, B-Cell | 11 | 2023 | 929 | 2.110 |
Why?
|
| Burkitt Lymphoma | 7 | 2022 | 333 | 1.870 |
Why?
|
| Epstein-Barr Virus Infections | 7 | 2022 | 599 | 1.850 |
Why?
|
| Antigens, CD20 | 5 | 2021 | 202 | 1.660 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 7 | 2021 | 167 | 1.530 |
Why?
|
| Mediastinal Neoplasms | 5 | 2020 | 401 | 1.500 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 9 | 2021 | 1396 | 1.480 |
Why?
|
| Proto-Oncogene Proteins c-myc | 7 | 2017 | 991 | 1.470 |
Why?
|
| Heavy Chain Disease | 5 | 2014 | 19 | 1.330 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 4 | 2021 | 124 | 1.320 |
Why?
|
| Flow Cytometry | 12 | 2020 | 5847 | 1.260 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 2 | 2020 | 44 | 1.240 |
Why?
|
| Breast Implants | 6 | 2021 | 399 | 1.170 |
Why?
|
| Lymphoma | 12 | 2024 | 1890 | 1.080 |
Why?
|
| Lymph Nodes | 10 | 2021 | 3483 | 1.050 |
Why?
|
| Immunophenotyping | 14 | 2021 | 1863 | 1.010 |
Why?
|
| Telepathology | 4 | 2012 | 77 | 0.940 |
Why?
|
| Diagnosis, Differential | 31 | 2023 | 12926 | 0.940 |
Why?
|
| Lymphoma, Non-Hodgkin | 6 | 2021 | 1372 | 0.820 |
Why?
|
| Lymphoma, Follicular | 3 | 2022 | 452 | 0.790 |
Why?
|
| Bartonella henselae | 1 | 2021 | 15 | 0.770 |
Why?
|
| Cat-Scratch Disease | 1 | 2021 | 23 | 0.770 |
Why?
|
| Herpesvirus 4, Human | 6 | 2023 | 1066 | 0.690 |
Why?
|
| Jaundice | 1 | 2019 | 90 | 0.670 |
Why?
|
| Inclusion Bodies | 1 | 2020 | 280 | 0.660 |
Why?
|
| Body Fluids | 1 | 2021 | 319 | 0.660 |
Why?
|
| Immunoproliferative Small Intestinal Disease | 1 | 2018 | 4 | 0.620 |
Why?
|
| Blood Cells | 1 | 2020 | 305 | 0.620 |
Why?
|
| Hematologic Neoplasms | 3 | 2022 | 1864 | 0.590 |
Why?
|
| Oligonucleotides | 1 | 2020 | 589 | 0.580 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2020 | 259 | 0.580 |
Why?
|
| Histiocytes | 2 | 2021 | 98 | 0.570 |
Why?
|
| Laboratories | 1 | 2021 | 460 | 0.570 |
Why?
|
| Pathology, Clinical | 5 | 2014 | 368 | 0.570 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 1524 | 0.560 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 6 | 2021 | 191 | 0.520 |
Why?
|
| Interferon Regulatory Factors | 2 | 2016 | 260 | 0.510 |
Why?
|
| Ethmoid Sinus | 1 | 2015 | 58 | 0.510 |
Why?
|
| Sphenoid Sinus | 1 | 2015 | 99 | 0.490 |
Why?
|
| Immunohistochemistry | 17 | 2023 | 11028 | 0.470 |
Why?
|
| Fibrin | 1 | 2017 | 504 | 0.470 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 240 | 0.460 |
Why?
|
| Biopsy, Fine-Needle | 6 | 2024 | 1113 | 0.460 |
Why?
|
| Plasmacytoma | 2 | 2014 | 171 | 0.450 |
Why?
|
| Cytodiagnosis | 2 | 2021 | 432 | 0.440 |
Why?
|
| Bone Marrow | 6 | 2014 | 2902 | 0.440 |
Why?
|
| Breast Implantation | 3 | 2021 | 223 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2019 | 8439 | 0.430 |
Why?
|
| Sarcoma, Kaposi | 2 | 2017 | 374 | 0.430 |
Why?
|
| Immunoglobulins | 3 | 2016 | 864 | 0.430 |
Why?
|
| Gene Rearrangement | 6 | 2021 | 1112 | 0.420 |
Why?
|
| Blood Cell Count | 3 | 2020 | 399 | 0.410 |
Why?
|
| Molluscum Contagiosum | 1 | 2012 | 14 | 0.410 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1774 | 0.410 |
Why?
|
| Humans | 120 | 2024 | 755533 | 0.400 |
Why?
|
| Hypercalcemia | 2 | 2013 | 416 | 0.400 |
Why?
|
| Lead Poisoning | 1 | 2014 | 311 | 0.390 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2011 | 53 | 0.380 |
Why?
|
| alpha-Thalassemia | 1 | 2011 | 51 | 0.380 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2178 | 0.380 |
Why?
|
| Multiple Myeloma | 4 | 2021 | 5120 | 0.370 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 592 | 0.370 |
Why?
|
| POEMS Syndrome | 1 | 2010 | 12 | 0.360 |
Why?
|
| DNA-Binding Proteins | 6 | 2024 | 9561 | 0.350 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.350 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2010 | 91 | 0.350 |
Why?
|
| Leukemia, Prolymphocytic, T-Cell | 1 | 2009 | 23 | 0.350 |
Why?
|
| Immunocompromised Host | 2 | 2012 | 856 | 0.340 |
Why?
|
| Bone Marrow Cells | 3 | 2019 | 2417 | 0.340 |
Why?
|
| Adult | 53 | 2024 | 217986 | 0.330 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3770 | 0.330 |
Why?
|
| Fractures, Compression | 1 | 2011 | 125 | 0.330 |
Why?
|
| Middle Aged | 55 | 2024 | 218055 | 0.330 |
Why?
|
| Carcinoma | 1 | 2021 | 2345 | 0.330 |
Why?
|
| Macrophages | 2 | 2020 | 5705 | 0.320 |
Why?
|
| Lead | 1 | 2014 | 860 | 0.310 |
Why?
|
| B-Lymphocytes | 3 | 2022 | 4706 | 0.310 |
Why?
|
| Antibodies, Neoplasm | 1 | 2009 | 280 | 0.310 |
Why?
|
| Female | 65 | 2024 | 387920 | 0.310 |
Why?
|
| Male | 59 | 2024 | 356577 | 0.310 |
Why?
|
| Aged | 44 | 2024 | 167376 | 0.300 |
Why?
|
| Sacrum | 1 | 2010 | 280 | 0.300 |
Why?
|
| Genes, myc | 3 | 2019 | 394 | 0.300 |
Why?
|
| Abdominal Pain | 1 | 2014 | 1062 | 0.290 |
Why?
|
| Bone Marrow Examination | 3 | 2019 | 156 | 0.290 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2009 | 255 | 0.290 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 594 | 0.280 |
Why?
|
| Aged, 80 and over | 24 | 2021 | 58549 | 0.280 |
Why?
|
| Fatal Outcome | 4 | 2013 | 1831 | 0.270 |
Why?
|
| Radiography | 8 | 2015 | 6975 | 0.270 |
Why?
|
| Translocation, Genetic | 3 | 2021 | 1386 | 0.270 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 14 | 2019 | 11606 | 0.270 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2015 | 906 | 0.260 |
Why?
|
| Spleen | 4 | 2019 | 2275 | 0.260 |
Why?
|
| Prognosis | 11 | 2024 | 29423 | 0.250 |
Why?
|
| Splenomegaly | 2 | 2011 | 189 | 0.250 |
Why?
|
| Amyloidosis | 1 | 2011 | 813 | 0.240 |
Why?
|
| Triage | 2 | 2023 | 983 | 0.240 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2017 | 3597 | 0.230 |
Why?
|
| Spinal Fractures | 1 | 2011 | 694 | 0.230 |
Why?
|
| Botswana | 3 | 2022 | 1022 | 0.230 |
Why?
|
| Africa, Eastern | 3 | 2012 | 73 | 0.230 |
Why?
|
| Plasma Cells | 5 | 2020 | 589 | 0.230 |
Why?
|
| Polymerase Chain Reaction | 5 | 2021 | 6066 | 0.220 |
Why?
|
| Bleomycin | 2 | 2012 | 497 | 0.220 |
Why?
|
| Biopsy | 7 | 2023 | 6760 | 0.220 |
Why?
|
| Stem Cell Transplantation | 3 | 2017 | 1601 | 0.220 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 10057 | 0.220 |
Why?
|
| Herpesviridae Infections | 3 | 2014 | 270 | 0.210 |
Why?
|
| Hematologic Tests | 2 | 2021 | 237 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3080 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3200 | 0.210 |
Why?
|
| Fever | 2 | 2021 | 1613 | 0.200 |
Why?
|
| Herpesvirus 8, Human | 5 | 2017 | 255 | 0.190 |
Why?
|
| Lumbar Vertebrae | 1 | 2011 | 1838 | 0.190 |
Why?
|
| DNA Mismatch Repair | 1 | 2024 | 428 | 0.190 |
Why?
|
| Flank Pain | 1 | 2021 | 43 | 0.190 |
Why?
|
| Germinal Center | 2 | 2015 | 379 | 0.190 |
Why?
|
| Mycoses | 1 | 2024 | 383 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2017 | 6521 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2012 | 672 | 0.180 |
Why?
|
| Erythroblasts | 1 | 2021 | 143 | 0.180 |
Why?
|
| Young Adult | 15 | 2021 | 58025 | 0.180 |
Why?
|
| Recurrence | 6 | 2021 | 8441 | 0.180 |
Why?
|
| Immunoglobulin gamma-Chains | 3 | 2014 | 33 | 0.170 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 20890 | 0.170 |
Why?
|
| Education, Medical | 1 | 2012 | 1719 | 0.170 |
Why?
|
| Treatment Outcome | 17 | 2021 | 64535 | 0.170 |
Why?
|
| Cats | 1 | 2021 | 968 | 0.170 |
Why?
|
| Histocytochemistry | 1 | 2020 | 691 | 0.170 |
Why?
|
| STAT6 Transcription Factor | 1 | 2019 | 186 | 0.170 |
Why?
|
| Urine | 1 | 2021 | 364 | 0.170 |
Why?
|
| Waldenstrom Macroglobulinemia | 3 | 2014 | 1065 | 0.170 |
Why?
|
| Hair Follicle | 1 | 2021 | 211 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2021 | 252 | 0.160 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2014 | 578 | 0.160 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2022 | 1623 | 0.160 |
Why?
|
| Predictive Value of Tests | 10 | 2021 | 15197 | 0.160 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 631 | 0.160 |
Why?
|
| Neoplasm Staging | 7 | 2021 | 11105 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 283 | 0.160 |
Why?
|
| Gene Fusion | 1 | 2021 | 352 | 0.160 |
Why?
|
| Africa South of the Sahara | 1 | 2021 | 728 | 0.160 |
Why?
|
| Splenic Neoplasms | 1 | 2008 | 96 | 0.160 |
Why?
|
| Cell Size | 1 | 2020 | 621 | 0.160 |
Why?
|
| Remote Consultation | 2 | 2012 | 229 | 0.150 |
Why?
|
| Campylobacter jejuni | 1 | 2018 | 25 | 0.150 |
Why?
|
| Campylobacter Infections | 1 | 2018 | 32 | 0.150 |
Why?
|
| Cytogenetic Analysis | 3 | 2014 | 272 | 0.150 |
Why?
|
| Treponema pallidum | 1 | 2018 | 47 | 0.150 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2018 | 79 | 0.150 |
Why?
|
| Neprilysin | 1 | 2021 | 464 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2021 | 367 | 0.150 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 535 | 0.150 |
Why?
|
| Nausea | 1 | 2021 | 673 | 0.150 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2523 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 776 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2017 | 23278 | 0.150 |
Why?
|
| Hematology | 1 | 2021 | 235 | 0.150 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2011 | 410 | 0.140 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2008 | 180 | 0.140 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2008 | 145 | 0.140 |
Why?
|
| Anemia | 4 | 2014 | 1503 | 0.140 |
Why?
|
| Disease-Free Survival | 6 | 2017 | 6793 | 0.140 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2017 | 178 | 0.140 |
Why?
|
| Vincristine | 5 | 2018 | 1030 | 0.140 |
Why?
|
| Diagnostic Errors | 3 | 2018 | 1248 | 0.140 |
Why?
|
| Alopecia | 1 | 2021 | 414 | 0.140 |
Why?
|
| Cholestasis | 1 | 2019 | 374 | 0.140 |
Why?
|
| Chromosome Aberrations | 2 | 2021 | 1769 | 0.140 |
Why?
|
| Remission Induction | 4 | 2021 | 2386 | 0.140 |
Why?
|
| Adolescent | 12 | 2019 | 87236 | 0.130 |
Why?
|
| Lymphatic Diseases | 2 | 2013 | 318 | 0.130 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2017 | 186 | 0.130 |
Why?
|
| Blood Coagulation Tests | 1 | 2007 | 270 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2021 | 706 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 1 | 2008 | 305 | 0.130 |
Why?
|
| Blotting, Southern | 2 | 2011 | 779 | 0.130 |
Why?
|
| Holography | 1 | 2016 | 80 | 0.130 |
Why?
|
| Orbital Pseudotumor | 1 | 2015 | 42 | 0.130 |
Why?
|
| Genes, bcl-2 | 1 | 2015 | 120 | 0.130 |
Why?
|
| In Situ Hybridization | 3 | 2015 | 1897 | 0.130 |
Why?
|
| Erythema | 1 | 2007 | 261 | 0.130 |
Why?
|
| Mouth | 1 | 2018 | 377 | 0.130 |
Why?
|
| Syphilis | 1 | 2018 | 240 | 0.130 |
Why?
|
| Dacryocystitis | 1 | 2015 | 70 | 0.120 |
Why?
|
| Orbital Cellulitis | 1 | 2015 | 35 | 0.120 |
Why?
|
| Travel | 1 | 2021 | 784 | 0.120 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2015 | 102 | 0.120 |
Why?
|
| Hypesthesia | 1 | 2015 | 107 | 0.120 |
Why?
|
| Neoplasm, Residual | 2 | 2017 | 999 | 0.120 |
Why?
|
| Paraproteinemias | 2 | 2014 | 247 | 0.120 |
Why?
|
| Retrospective Studies | 17 | 2021 | 79686 | 0.120 |
Why?
|
| Prednisone | 5 | 2018 | 1564 | 0.120 |
Why?
|
| Thrombophilia | 1 | 2007 | 307 | 0.120 |
Why?
|
| Porphyrias | 1 | 2014 | 58 | 0.120 |
Why?
|
| Disease Progression | 5 | 2021 | 13427 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1081 | 0.120 |
Why?
|
| Blepharoptosis | 1 | 2015 | 144 | 0.110 |
Why?
|
| Sialadenitis | 1 | 2014 | 45 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2016 | 4280 | 0.110 |
Why?
|
| World Health Organization | 3 | 2022 | 1308 | 0.110 |
Why?
|
| Diplopia | 1 | 2015 | 214 | 0.110 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2003 | 66 | 0.110 |
Why?
|
| Polycythemia | 1 | 2014 | 125 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9109 | 0.110 |
Why?
|
| Jaw | 1 | 2013 | 93 | 0.110 |
Why?
|
| Transaminases | 1 | 2014 | 196 | 0.110 |
Why?
|
| Cyclophosphamide | 5 | 2018 | 2197 | 0.110 |
Why?
|
| Sarcoma, Myeloid | 1 | 2013 | 52 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2017 | 727 | 0.110 |
Why?
|
| Skin Diseases | 2 | 2012 | 1090 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 419 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2021 | 20404 | 0.110 |
Why?
|
| Mutation | 7 | 2024 | 29807 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 2476 | 0.100 |
Why?
|
| Doxorubicin | 5 | 2018 | 2196 | 0.100 |
Why?
|
| Urologic Neoplasms | 1 | 2006 | 321 | 0.100 |
Why?
|
| Hematuria | 1 | 2013 | 233 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 557 | 0.100 |
Why?
|
| Disease Management | 2 | 2020 | 2484 | 0.100 |
Why?
|
| Lupus Nephritis | 1 | 2005 | 315 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 2020 | 2820 | 0.100 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2011 | 30 | 0.100 |
Why?
|
| Data Collection | 1 | 2021 | 3306 | 0.100 |
Why?
|
| Orbit | 1 | 2015 | 445 | 0.100 |
Why?
|
| Time Factors | 5 | 2021 | 39961 | 0.100 |
Why?
|
| Immunoglobulin G | 4 | 2018 | 4523 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 827 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2021 | 23956 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2016 | 1095 | 0.100 |
Why?
|
| Autoimmune Diseases | 2 | 2015 | 2228 | 0.100 |
Why?
|
| Pleural Effusion | 2 | 2009 | 339 | 0.100 |
Why?
|
| Antigens, CD | 2 | 2020 | 3910 | 0.100 |
Why?
|
| Ischemic Attack, Transient | 1 | 2007 | 903 | 0.100 |
Why?
|
| Confusion | 1 | 2013 | 274 | 0.100 |
Why?
|
| Microscopy, Video | 1 | 2012 | 242 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2020 | 2512 | 0.100 |
Why?
|
| Acute Disease | 2 | 2014 | 7224 | 0.100 |
Why?
|
| Gaucher Disease | 1 | 2012 | 110 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 610 | 0.100 |
Why?
|
| Maryland | 1 | 2011 | 271 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2001 | 1744 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1743 | 0.090 |
Why?
|
| Pancytopenia | 1 | 2012 | 101 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2020 | 2058 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2017 | 1289 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 381 | 0.090 |
Why?
|
| Hydrocephalus | 1 | 2017 | 758 | 0.090 |
Why?
|
| Thalassemia | 1 | 2011 | 270 | 0.090 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2011 | 277 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 2012 | 444 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2013 | 532 | 0.090 |
Why?
|
| Umbilical Veins | 1 | 2001 | 425 | 0.090 |
Why?
|
| Cell Count | 1 | 2014 | 1832 | 0.090 |
Why?
|
| Nephritis, Interstitial | 1 | 2011 | 155 | 0.090 |
Why?
|
| Antigens, CD19 | 1 | 2013 | 413 | 0.090 |
Why?
|
| Codon | 1 | 2011 | 601 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 1894 | 0.090 |
Why?
|
| Fatigue | 2 | 2014 | 1531 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 1388 | 0.090 |
Why?
|
| Weight Loss | 1 | 2021 | 2667 | 0.080 |
Why?
|
| Oncogenes | 1 | 2015 | 1217 | 0.080 |
Why?
|
| Headache | 1 | 2017 | 1238 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2012 | 544 | 0.080 |
Why?
|
| Europe | 1 | 2016 | 3407 | 0.080 |
Why?
|
| Varicose Veins | 1 | 2001 | 155 | 0.080 |
Why?
|
| Reed-Sternberg Cells | 1 | 2009 | 72 | 0.080 |
Why?
|
| Bradycardia | 1 | 2011 | 298 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 1451 | 0.080 |
Why?
|
| Data Mining | 1 | 2014 | 548 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 1341 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2021 | 4211 | 0.080 |
Why?
|
| Observer Variation | 2 | 2012 | 2593 | 0.080 |
Why?
|
| Cardiomegaly | 1 | 2011 | 593 | 0.080 |
Why?
|
| Activins | 1 | 2010 | 210 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2019 | 2610 | 0.080 |
Why?
|
| Surface Properties | 2 | 2021 | 1155 | 0.080 |
Why?
|
| Brachial Plexus | 1 | 2010 | 163 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2016 | 5566 | 0.080 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2012 | 662 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 1790 | 0.080 |
Why?
|
| Osteolysis | 1 | 2010 | 271 | 0.080 |
Why?
|
| Ascites | 1 | 2010 | 338 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21907 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 13577 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 2067 | 0.080 |
Why?
|
| Karyotyping | 1 | 2010 | 1184 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 2015 | 649 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2021 | 3521 | 0.070 |
Why?
|
| Antigens, Viral | 1 | 2012 | 979 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 495 | 0.070 |
Why?
|
| Survival Rate | 4 | 2017 | 12782 | 0.070 |
Why?
|
| Neutrophils | 1 | 2020 | 3735 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2012 | 2496 | 0.070 |
Why?
|
| Demyelinating Diseases | 1 | 2010 | 343 | 0.070 |
Why?
|
| Treatment Failure | 2 | 2013 | 2637 | 0.070 |
Why?
|
| United States | 7 | 2023 | 71888 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2013 | 1170 | 0.070 |
Why?
|
| Testicular Neoplasms | 1 | 2013 | 797 | 0.070 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2009 | 584 | 0.070 |
Why?
|
| HIV Infections | 5 | 2022 | 17053 | 0.070 |
Why?
|
| Back Pain | 1 | 2011 | 541 | 0.070 |
Why?
|
| Bone Diseases, Developmental | 1 | 1997 | 127 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7342 | 0.070 |
Why?
|
| Anti-Retroviral Agents | 2 | 2012 | 1773 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2016 | 10180 | 0.070 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2005 | 14 | 0.070 |
Why?
|
| Inflammation | 2 | 2017 | 10717 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 3 | 2014 | 694 | 0.070 |
Why?
|
| HIV Seropositivity | 1 | 2012 | 956 | 0.070 |
Why?
|
| Pre-Eclampsia | 1 | 2005 | 1219 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2016 | 1137 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 3471 | 0.070 |
Why?
|
| Pilonidal Sinus | 1 | 2005 | 17 | 0.070 |
Why?
|
| Sacrococcygeal Region | 1 | 2005 | 54 | 0.070 |
Why?
|
| Child | 7 | 2021 | 79427 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 2900 | 0.070 |
Why?
|
| Adenoma | 1 | 2006 | 2144 | 0.060 |
Why?
|
| Visual Acuity | 1 | 2015 | 2608 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2021 | 3824 | 0.060 |
Why?
|
| Fetal Diseases | 1 | 2001 | 912 | 0.060 |
Why?
|
| Sclerosis | 2 | 2015 | 211 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 1674 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2009 | 512 | 0.060 |
Why?
|
| Natural Language Processing | 1 | 2014 | 1116 | 0.060 |
Why?
|
| Lymphocytes | 2 | 2012 | 2597 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14636 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2017 | 9180 | 0.060 |
Why?
|
| Logistic Models | 1 | 2020 | 13315 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8013 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2014 | 2405 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2012 | 5180 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2021 | 2125 | 0.060 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2010 | 696 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2022 | 2562 | 0.060 |
Why?
|
| Tissue Array Analysis | 2 | 2017 | 551 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2011 | 2828 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2017 | 41893 | 0.050 |
Why?
|
| Gene Expression | 2 | 2013 | 7587 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 4515 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2001 | 2869 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2010 | 1532 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 3758 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3606 | 0.050 |
Why?
|
| Government Agencies | 1 | 2022 | 162 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2005 | 2326 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2010 | 2001 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2022 | 53991 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2015 | 36042 | 0.050 |
Why?
|
| Poly(A)-Binding Protein I | 1 | 2021 | 15 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 2924 | 0.050 |
Why?
|
| Abdomen | 1 | 1997 | 1114 | 0.050 |
Why?
|
| Fungi | 1 | 2024 | 333 | 0.050 |
Why?
|
| Femur | 1 | 1997 | 1290 | 0.050 |
Why?
|
| Immunoglobulin M | 2 | 2012 | 1518 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2011 | 2551 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39179 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 5784 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 19987 | 0.040 |
Why?
|
| Obesity | 1 | 2022 | 12843 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8565 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2012 | 2150 | 0.040 |
Why?
|
| Kidney | 2 | 2011 | 7009 | 0.040 |
Why?
|
| Lung | 2 | 2014 | 9918 | 0.040 |
Why?
|
| Risk Factors | 3 | 2021 | 73860 | 0.040 |
Why?
|
| Internet | 1 | 2011 | 3073 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 1884 | 0.040 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 2008 | 15 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 13952 | 0.040 |
Why?
|
| Paraproteins | 1 | 2008 | 38 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2003 | 2879 | 0.040 |
Why?
|
| Echocardiography | 1 | 2011 | 4957 | 0.040 |
Why?
|
| Hospitals, General | 2 | 2014 | 767 | 0.040 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2008 | 71 | 0.040 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2008 | 70 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2012 | 3580 | 0.040 |
Why?
|
| Boston | 1 | 2011 | 9254 | 0.040 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2008 | 71 | 0.040 |
Why?
|
| Pain | 1 | 2013 | 4999 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8487 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2014 | 3779 | 0.040 |
Why?
|
| Skin | 1 | 2012 | 4445 | 0.040 |
Why?
|
| Ribosomal Protein S6 | 1 | 2017 | 71 | 0.040 |
Why?
|
| Splenectomy | 1 | 2008 | 390 | 0.040 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 5785 | 0.040 |
Why?
|
| Ascitic Fluid | 1 | 2007 | 190 | 0.040 |
Why?
|
| Pregnancy | 4 | 2009 | 29543 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2018 | 280 | 0.030 |
Why?
|
| Classification | 1 | 2017 | 127 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2009 | 5937 | 0.030 |
Why?
|
| Cytogenetics | 1 | 2017 | 198 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 4910 | 0.030 |
Why?
|
| Heart Failure | 2 | 2011 | 11781 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 5286 | 0.030 |
Why?
|
| Cerebral Veins | 1 | 2007 | 155 | 0.030 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2006 | 83 | 0.030 |
Why?
|
| Clinical Chemistry Tests | 1 | 2005 | 58 | 0.030 |
Why?
|
| Mass Screening | 1 | 2011 | 5413 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 1597 | 0.030 |
Why?
|
| Phototherapy | 1 | 2008 | 367 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3502 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2008 | 349 | 0.030 |
Why?
|
| Thyroiditis | 1 | 2005 | 87 | 0.030 |
Why?
|
| Ifosfamide | 1 | 2015 | 232 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12500 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1332 | 0.030 |
Why?
|
| Paraffin | 1 | 2014 | 37 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 8555 | 0.030 |
Why?
|
| Pericardial Effusion | 1 | 2007 | 245 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5187 | 0.030 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2006 | 220 | 0.030 |
Why?
|
| Stroke | 1 | 2007 | 9904 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 2005 | 224 | 0.030 |
Why?
|
| Databases, Factual | 3 | 2015 | 7946 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2015 | 313 |